Prevalence of Hepatitis D virus infection among Hepatitis B virus infected patients in Qom Province, Center of Iran

Hepatitis Monthly

Volumn 12, Issue 3, 2012, Pages 205-208

  Ghadir, Mohammad Reza ^a   Belbasi, Mojtaba ^b   Heidari, Akram ^a   Sarkeshikian, Seyed Saeid ^a   Kabiri, Alireza ^b   Ghanooni, Amir Hossein ^a   Iranikhah, Abolfazl ^a   Vaez Javadi, Maryam ^a   Alavian, Seyed Moayed ^c  

^a QOM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRANIAN BLOOD TRANSFUSION ORGANIZATION   (Iran)

^c BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hepatitis B virus; Hepatitis D; Iran; Prevalence

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ARTICLE; CROSS-SECTIONAL STUDY; DELTA AGENT HEPATITIS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS DELTA VIRUS; HUMAN; IRAN; MALE; QUESTIONNAIRE; RISK FACTOR; SEROPREVALENCE; TATTOOING;

EID: 84860997319     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/hepatmon.5121     Document Type: Article

References (25)

1. Jacobson IM, Dienstag JL, Werner BG, Brettler DB, Levine PH, Mushahwar IK. Epidemiology and clinical impact of hepatitis D virus (delta) infection. Hepatology. 1985;5(2):188-91.
2. Tapalaga D, Forzani B, Hele C, Paravacini O, Ponzetto A, Theilmann L. Prevalence of the hepatitis delta virus in Rumania. Hepatogastroenterology. 1986;33(6):238-9.
3. Gaeta GB, Stroffolini T, Chiaramonte M, Ascione T, Stornaiuolo G, Lobello S, et al. Chronic hepatitis D: a vanishing Disease? An Italian multicenter study. Hepatology. 2000;32(4 Pt 1):824-7.
4. Ivaniushina VA, Ryzhova EV, Grudinin MP, Katorgina LG, Nikonova AN, Vinogradova EN, et al. [The frequency of antibodies against delta virus in patients with HBs positive hepatitis]. Vopr Virusol. 1996;41(4):166-9.
5. Alavian S, Asari S, Manzoori-Joybari H, Moghani Lankarani M, Doroudi T, HajiBeigi B, et al. Frequency and risk factors of hepatitis D virus in hepatitis B patients Govaresh. 2005;10(1):21-6.
6. Alavian SM, Manzoori-Joybari H, Asari SH, Moghani Lankarani M. Is a war injury history a risk factor for HDV infection? J Military Med. 2005;7(2):95-9.
7. Zaki H, Darmstadt GL, Baten A, Ahsan CR, Saha SK. Seroepidemiology of hepatitis B and delta virus infections in Bangladesh. J Trop Pediatr. 2003;49(6):371-4.
8. Alavian SM, Mostajabi P, Malekzadeh R, Azimi K, Vosough H, Sarrafi M. [Evaluation of Hepatitis B Transmission Risk Factors in Tehran Blood Donors]. Govaresh. 2004;3(9):169-75.
9. Alavian SM, Fallahian F, Lankarani KB. The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis. 2007;16(4):403-6.
10. de Miguel J, Collazos J, Mayo J, Lopez de Goicoechea MJ, Echaniz C, Mendarte U. [Seroprevalence of delta virus and hepatitis C virus in patients with chronic infection with hepatitis B virus]. Rev Clin Esp. 1994;194(10):897-900.
11. Belshe R. Textbook of human virology. Mosby-Year. 2nd ed; 1990.
12. Malekzadeh R, Borhanmanesh F. Prevalence of HDV in asymptomatic healthy carrier of HBV in Iran. Irn J Med Sci. 1989;14(2):33-8.
13. Taghavi S, Sedighi S, Mehrabani D, Khademolhosseini F. Hepatitis D in chronic active hepatitis B: prevalence, liver enzymes and histopathology- an epidemiological study in Shiraz, southern Iran, 2003-2004. Hepat Mon. 2008;8(4):248-51.
14. Amini S, Mahmoodi MF, Andalibi S, Solati AA. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study. J Trop Med Hyg. 1993;96(5):277-87.
15. Rezvan H, Forouzandeh B, Taroyan S, Fadaiee S, Azordegan F. A study on delta virus infection and its clinical impact in Iran. Infection. 1990;18(1):26-8.
16. Karimi A, Amini S, Amirkhani A. [Investigation and Comparison of hepatitis D prevalence in dialysis patients and the donors of HBsAg carrier]. Teb va Tazkieh. 2000;36:30-5.
17. Roshandel G, Semnani S, Abdolahi N, Keshtkar A, Besharat S, Joshaghni H, et al. Prevalence of Hepatitis D Virus Infection in HBsAg Positive Subjects in Iran. Pakistan J Bio Sci. 2007;10(10):1751-4.
18. Gholamreza R, Shahryar S, Abbasali K, Hamidreza J, Abdolvahab M, Khodaberdi K, et al. Seroprevalence of hepatitis B virus and its co-infection with hepatitis D virus and hepatitis C virus in Iranian adult population. Indian J Med Sci. 2007;61(5):263-8.
19. Roshandel G, Semnani S, Abdolahi N, Besharat S, Keshtkar AA, Joshaqani H, et al. Prevalence of hepatitis D virus infection in hepatitis B surface antigen-positive subjects in Golestan province, northeast Iran. J Microbiol Immunol Infect. 2008;41(3):227-30.
20. Hassanjani Roshan M, Beigi A, Soleimani M. [Prevalence of anti-HDV in chronic carrier of HBV in Babol]. Babol Med J. 2002;6(21):50-4.
21. Zahedi M. [Serologic Prevalence of Hepatitis D in HBsAg Positive Patients in Kerman, South of Iran, 2002-2003]. Kerman Univ Med Sci Health Serv. Document No. 81/55.2003.
22. Torabi S, Ebrahim Poor S, Maljaei S, Naghili B. [Seroepidemiological studies of Hepatitis Delta (HDV) in HBsAg positive individuals in Tabriz]. Urmia Med J. 2003;4(13):290-7.
23. Vaziri S, Mansouri F, Sayad B, Afsharian M, Janbakhsh A, Karami M. A Study of Hepatitis D Virus Infection Among HIV Infected Patients in Kermanshah, West of Iran. Hepat Mon. 2008;8(4):252-7.
24. Christensen B, Olesen F, Ostergaard I. [Depression as a side effect of treatment with flunarizine?]. Ugeskr Laeger. 1988;150(46):2827-8.
25. Alavian S. We Have More Data Regarding Epidemiology of Hepatitis D in Iran but There are Defects to be Filled Yet. Hepat Mon. 2008;8(4);245-7.